GlobeNewswire
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
📈
AI Sentiment
Highly Positive
8/10
- Home
- IART
as of 11-28-2025 12:33pm EST
$13.03
$0.09
-0.69%
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Chart Type:
Time Range:
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | PRINCETON |
| Market Cap: | 1.2B | IPO Year: | 1995 |
| Target Price: | $15.00 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Hold | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $10.87 - $27.13 | Next Earning Date: | 10-30-2025 |
| Revenue: | $1,642,966,000 | Revenue Growth: | 4.99% |
| Revenue Growth (this year): | 3.51% | Revenue Growth (next year): | 2.88% |
AI-Powered IART Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 75.68%
75.68%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Integra LifeSciences Holdings Corporation (IART)
GRAVES JEFFREY A
Buy
Director
IART Nov 5, 2025
Avg Cost/Share
$11.35
Shares
9,000
Total Value
$102,150.00
Owned After
41,086
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| GRAVES JEFFREY A | IART | Director | Nov 5, 2025 | Buy | $11.35 | 9,000 | $102,150.00 | 41,086 |
Latest Integra LifeSciences Holdings Corporation News
IART Breaking Stock News: Dive into IART Ticker-Specific Updates for Smart Investing
Compare IART vs Leading Stocks
See how IART stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IART Integra LifeSciences Holdings Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.